During a world first therapy conducted at the Princess Alexandra Hospital by Mater Researcher and Haematologist Professor Maher Gandhi a 46-year-old patient has been successfully cured of a rare type of lymphoma. Image credit: Pixabay (Free Pixabay license) The patient was diagnosed with brain lymphoma, a form of blood cancer confined to the brain, following...
Higher BMI is linked to decreased cerebral blood flow, which is associated with increased risk of Alzheimer’s disease and mental illness 3-D RENDERINGS OF BLOOD FLOW AVERAGED ACROSS NORMAL BMI (BMI = 23), OVERWEIGHT (BMI = 29), AND OBESE (BMI = 37) MEN, EACH 40 YEARS OF AGE. CREDIT: AMEN CLINICS. view more CREDIT: AMEN...
Canadian scientists have achieved a first in the study of telomerase, an essential enzyme implicated in aging and cancer. In today’s edition of the prestigious journal Molecular Cell, scientists from Université de Montréal used advanced microscopy techniques to see single molecules of telomerase in living cells. A flaw in the replication of chromosomes means that...
U of A PhD candidate studies and participates in grassroots movement to hack diabetes equipment. People with Type 1 diabetes—including U of A graduate student Jonathan Garfinkel—are using free instructions from the internet to build an artificial pancreas. The patient-led movement is pushing pharmaceutical companies to improve the treatments they offer, according to U of...
by Chris Melore COLUMBUS, Ohio — A scientific breakthrough has given a man in Ohio the chance to reclaim a major part of his life after a devastating injury. Ian Burkhart suffered a severe spinal cord injury in 2010 while on vacation from Ohio University. He dove into a wave and struck an unseen sandbar...
In an extraordinary step forward for the psychedelic drug research community, the US Food and Drug Administration (FDA) has just given psilocybin therapy for treatment-resistant depression a Breakthrough Therapy designation. This classification suggests the treatment has demonstrated significant potential in early clinical evidence, allowing the FDA to assist and expedite subsequent development and review processes....
